Patent details

Basic Information

Publication number:

EP2672985

PCT Application Number:

PCT/SE/2012/050124

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP127444107

PCT Publication Number:

WO/2012/108828

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CITRATE FREE PHARMACEUTICAL COMPOSITIONS COMPRISING ANAKINRA

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES À BASE D'ANAKINRA, EXEMPTES DE CITRATES

German Title of Invention:

CITRATFREIE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT ANAKINRA

SPC Number:

Dates

Filing date:

09/02/2012

Grant date:

27/04/2016

EP Publication Date:

27/04/2016

PCT Publication Date:

16/08/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/12/2013

EP B1 Publication Date:

27/04/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

09/02/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/02/2012

 

 

Name:

Swedish Orphan Biovitrum AB (Publ)

Address:

-, 112 76 Stockholm, Sweden (SE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

06/07/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

FRANSSON Jonas

Address:

Sweden (SE)

2

Name:

FLORIN-ROBERTSSON Ebba

Address:

Sweden (SE)

Priority

Priority Number:

1150109

Priority Date:

11/02/2011

Priority Country:

Sweden (SE)

Classification

Main IPC Class:

A61K 38/20;

Annual Fees

Annual Fee Due Date:

01/03/2027

Annual Fee Number:

16

Annual Fee Amount:

230 Euro

Expected Payer:

Last Annual Fee Payment Date:

15/01/2026

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

AWA SWEDEN AB

Filing date	Document type	Number of pages